home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

CARBOGEN AMCIS

SHARESHARESHARE
CARBOGEN AMCIS is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. The integrated services of CARBOGEN AMCIS provide innovative, timely and safe drug development solutions that allow customers to make the best use of their available resources. CARBOGEN AMCIS’ focus is on supporting the development process from bench to market.
SHARESHARESHARE

RELATED NEWS


At the core of nMS is the ability to preserve non-covalent interactions and perform very accurate mass measurements. This ability has enabled advances in structural biology, including the elucidation of protein homogeneity, oligomeric state, sequence variation and the identity of bound ligands. These advances are made possible by preserving proteins in their native state in solution, followed by careful transfer into the gas phase of the mass spectrometer. As a consequence, nMS is finding applic...

READ MORE

Researchers at the University of Arizona have developed an advanced optogenetics device that can stimulate multiple areas of the brain at once and control the intensity of emitted light. The miniaturized device is wireless and battery-free, and the researchers hope that it will pave the way to treating severe neurological disorders and controlling chronic pain. Optogenetics involves loading specific neurons with proteins called opsins, which can stimulate a neuron to fire when exposed to light. ...

READ MORE

French biotech Abivax’s might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment. The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464. The study aimed at accessing the effects of Abivax treatment on HIV DNA in blood and in rectal tissue in HIV patients and was conducted at the Germa...
PHARMAPHORUM
READ MORE

Health practitioners who are male and older than 45 are at the highest risk of being the subject of a complaint, according to an Australian study of 8000....
PHARMACYNEWS
READ MORE

Bayer has completed its rolling marketing application for prostate cancer drug darolutamide in the US, setting up possible approval later this year and a market clash with Pfizer/Astellas and Johnson & Johnson. The filing is based on data from the phase III ARAMIS trial of Orion-partnered darolutamide plus androgen deprivation therapy (ADT) in patients with non-metastatic castration-resistant prostate cancer (CRPC). The results were published in the New England Journal of Medicine earlier th...

READ MORE

Eisai Co., Ltd. announced today that, in alignment with Chinese regulations, it has temporarily withdrawn its new drug application for anticancer agent eribulin mesylate (Brand name: Halaven) in China in order to submit additional documentation. No additional clinical trials have been scheduled, and resubmission will take place as soon as the additional documentation is prepared. In July 2016, Eisai submitted a new drug application for Halaven seeking approval as a treatment for locally advanced...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...